Literature DB >> 10731462

Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study.

H A Feldman1, C B Johannes, C A Derby, K P Kleinman, B A Mohr, A B Araujo, J B McKinlay.   

Abstract

BACKGROUND: Erectile dysfunction (ED), a wide spread and troublesome condition among middle-aged men, is partly vascular in origin. In the Massachusetts Male Aging Study, a random-sample cohort study, we investigated the relationship between baseline risk factors for coronary heart disease and subsequent ED, on the premise that subclinical arterial insufficiency might be manifested as ED.
METHODS: Men ages 40-70, selected from state census lists, were interviewed in 1987-1989 and reinterviewed in 1995-1997. Data were collected and blood was drawn in participants' homes. ED was assessed from responses to a privately self-administered questionnaire. Analysis was restricted to 513 men with no ED at baseline and no diabetes, heart disease, or related medications at either time.
RESULTS: Cigarette smoking at baseline almost doubled the likelihood of moderate or complete ED at followup (24% vs. 14%, adjusted for age and covariates, P = 0.01). Cigar smoking and passive exposure to cigarette smoke also significantly predicted incident ED, as did overweight (body-mass index > or =28 kg/m(2)) and a composite coronary risk score. Weaker prospective associations were seen for hypertension and dietary intake of cholesterol and unsaturated fat.
CONCLUSIONS: Erectile dysfunction and coronary heart disease share some behaviorally modifiable determinants in men who, like our sample, are free of manifest ED or predisposing illness. Open questions include whether modification of coronary risk factors can prevent ED and whether ED may serve as a sentinel event for coronary disease. Copyright 2000 American Health Foundation and Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 10731462     DOI: 10.1006/pmed.2000.0643

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  121 in total

Review 1.  Erectile dysfunction and atherosclerosis.

Authors:  Robert A Kloner; Mark Speakman
Journal:  Curr Atheroscler Rep       Date:  2002-09       Impact factor: 5.113

Review 2.  Common conditions of the aging male: erectile dysfunction, benign prostatic hyperplasia, cardiovascular disease and depression.

Authors:  L Zakaria; A G Anastasiadis; R Shabsigh
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

Review 3.  Should patients with erectile dysfunction be evaluated for cardiovascular disease?

Authors:  Kenneth A Ewane; Hao-Cheng Lin; Run Wang
Journal:  Asian J Androl       Date:  2011-11-28       Impact factor: 3.285

4.  Current Diagnosis and Management of Erectile Dysfunction.

Authors:  Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2014-09

5.  Erectile dysfunction and smoking: subverting tobacco industry images of masculine potency.

Authors:  S Chapman
Journal:  Tob Control       Date:  2006-04       Impact factor: 7.552

6.  Endothelial dysfunction, erectile dysfunction, and coronary heart disease: the pathophysiologic and clinical linkage.

Authors:  Richard A Stein
Journal:  Rev Urol       Date:  2003

Review 7.  [Hypogonadism in the elderly man. Reliable diagnosis and therapy].

Authors:  M Zitzmann; E Nieschlag
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

8.  Predictors of Erectile Function Normalization in Men With Erectile Dysfunction Treated With Placebo.

Authors:  John P Mulhall; Martin Carlsson; Vera Stecher; Li-Jung Tseng
Journal:  J Sex Med       Date:  2018-05-09       Impact factor: 3.802

Review 9.  From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome.

Authors:  M I Maiorino; G Bellastella; D Giugliano; K Esposito
Journal:  J Endocrinol Invest       Date:  2018-03-16       Impact factor: 4.256

10.  Golombok Rust Inventory of Sexual Satisfaction for the presence of sexual dysfunction within a Ghanaian urological population.

Authors:  N Amidu; L Quaye; A A Afoko; P Karikari; B B N Gandau; E O Amoah; E Nuwoku
Journal:  Int J Impot Res       Date:  2014-01-16       Impact factor: 2.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.